Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART: Smallpox Vaccine for Mpox Post-Exposure Prophylaxis
NCT05745987Phase 4Active, not recruiting
- Sponsor
- McMaster University
- Start
- Sep 2024
- Primary completion
- Apr 2026
- Modality
- Live Attenuated Vaccines
- Countries
- 3
01
Overview
A Phase 4 trial of JYNNEOS in mpox, sponsored by McMaster University. Started Sep 2024; status: active, not recruiting.
02
Drugs
JYNNEOS
03
Conditions
mpox
Beyond the preview
Go deeper on NCT05745987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05745987.